Marshall Wace North America’s Adaptimmune Therapeutics ADAP Stock Holding History

Marshall Wace North America’s Portfolio ADAP Stock Details ADAP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$304K	Buy
2020 Q4	–	Sell
2020 Q3	$1.23M	Sell
2020 Q2	$4.38M	Buy